MD Aleksandar Aleksić

MD Aleksandar Aleksić
Specific Professional Orientation:
Dr. Aleksandar Aleksić is a specialist in internal medicine, with cardiology as his primary scientific field. Dr. Aleksić has over 29 years of professional experience in both public hospitals and clinical centers, as well as in private hospitals and medical systems. He is a regular participant and lecturer at international and national congresses and workshops. He is a member of both domestic and European cardiology associations and has completed professional training in Belgium, China, Germany, and Macedonia.
Education:
1996 – Faculty of Medicine, University of Belgrade – Doctor of Medicine
2002 – Faculty of Medicine, University of Belgrade – Specialist in Internal Medicine
Work Experience:
- 2025 – Puls Cardiology Center
- 2024 – Dragiša Mišović Clinical Hospital Center
- 2022 – 2024 – Euromedik
- 2003 – 2022 – Zemun Clinical Hospital Center
Advanced medical training:
- 2011 (Dec) Specialization in FFR (Fraction Flow Reserve) and renal denervation, OLVZ, Aalst, Belgium 2008 (Sep) Specialization in IABP (Intraaortic balloon pump), Herzzentrum, Liepzig, Germany
- Nov 2016 – Oct 2017 CARVAR heart center, Yinchuan, China. Consultant for cardiac surgery program and education for new methods in Cardiology.
- 2014 – Interventional cardiology consultant Bitolj, Ohrid, Strumica, Stip, FYR Macedonia.
Participation in Congresses and Workshops:
- Spring Cardiology Workshop (2019, 2020, 2021, 2022)
- Congress of Coronary Care Units of Serbia (2019, 2020, 2021)
- Zaječar Symposium of Interventional Cardiology – ZASINK (2019, 2020, 2021)
- National Congress of Cardiologists (2021)
Memberships:
- Cardiology Society of Serbia (UKS)
- Echocardiographic Society of Serbia (EHOS)
- European Society of Cardiology (ESC)
Reference:
1: Ilić I, Stanković I, Vidaković R, Janićijević A, Cerović M, Jovanović V, Aleksić A, Obradović G, Nikolajević I, Kafedzić S, Milicević D, Kusić J, Putniković B, Nesković AN. Influence of manual thrombus aspiration on left ventricular diastolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Srp Arh Celok Lek. 2016 Jan-Feb;144(1-2):23-30. PubMed PMID: 27276854.
2: Ilic I, Stankovic I, Ilisic B, Cerovic M, Aleksic A, Nikolajevic I, Kafedzic S, Cuellas Ramon C, Sokolov M, El Setecha M, Putnikovic B, Neskovic AN. Favorable outcomes in octogenarians treated with bioresorbable polymer drug-eluting stent. Geriatr Gerontol Int. 2016 Dec;16(12):1246-1253. doi: 10.1111/ggi.12619. Epub 2015 Oct 13. PubMed PMID: 26735289.
3: Stojkovic S, Neskovic AN, Mehmedbegovic Z, Kafedzic S, Ostojic M, Nedeljkovic M, Orlic D, Ilisic B, Ilic I, Aleksic A, Cerovic M, Nikolajevic I, Vlahovic-Stipac A, Stajic Z, Putnikovic B, Hamilos M. Reduced sirolimus systemic exposure and improved bioresorbable polymer properties: new allies for the treatment of patients with coronary artery disease. Fundam Clin Pharmacol. 2015 Feb;29(1):95-105. doi: 10.1111/fcp.12092. Epub 2014 Dec 11. PubMed PMID: 25223651.
4: Putniković B, Ilić I, Panić M, Aleksić A, Vidaković R, Nesković AN. Spontaneous coronary artery dissection- rare but challenging. Vojnosanit Pregl. 2014 Mar;71(3):311-6. PubMed PMID: 24697021.